as 04-24-2025 2:34pm EST
Founded: | 1859 | Country: | United States |
Employees: | N/A | City: | NORTH CANTON |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $65.00 | AVG Volume (30 days): | 158.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.44 | EPS Growth: | N/A |
52 Week Low/High: | $30.37 - $51.81 | Next Earning Date: | 05-07-2025 |
Revenue: | $3,751,100,000 | Revenue Growth: | -0.25% |
Revenue Growth (this year): | 1.7% | Revenue Growth (next year): | 1.89% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
PEARLMAN EMANUEL R | DBD | Director | Feb 28 '25 | Sell | $43.68 | 2,000 | $87,360.00 | 41,000 | |
Capital World Investors | DBD | 10% Owner | Feb 27 '25 | Sell | $43.65 | 19,842 | $866,103.30 | 335,869 |
DBD Breaking Stock News: Dive into DBD Ticker-Specific Updates for Smart Investing
Zacks
21 hours ago
PR Newswire
a day ago
StockStory
6 days ago
Zacks
7 days ago
StockStory
8 days ago
Zacks
9 days ago
Zacks
14 days ago
Zacks
16 days ago
The information presented on this page, "DBD Diebold Nixdorf Incorporated Common stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.